For example, breast and ovarian cancers frequently possess mutations of BRCA1 or BRCA2, which are vital genes of homologous recombination (HR), and these cancers often show the mutation signature with a distinctive pattern of substitutions and deletions63. This evidence concerns the gene BRCA1 and cancer.